BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30663903)

  • 21. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
    Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
    Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases.
    Fan H; Wang X; Qu J; Lu W; Xu S; Wu X; Xia J; Zhang Y; Sun J; Yang X
    Front Oncol; 2021; 11():678490. PubMed ID: 34055647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Laimer G; Jaschke N; Schullian P; Putzer D; Eberle G; Solbiati M; Solbiati L; Goldberg SN; Bale R
    Eur Radiol; 2021 Sep; 31(9):6489-6499. PubMed ID: 33447860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
    Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of radiofrequency ablation and transcatheter arterial chemoembolization to treat hepatocellular carcinoma: measurement of distance from needle tip to nodule for assessment of local tumor progression.
    Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
    J Int Med Res; 2019 Jun; 47(6):2516-2523. PubMed ID: 31020891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.
    Ziv E; Erinjeri JP; Yarmohammadi H; Boas FE; Petre EN; Gao S; Shady W; Sofocleous CT; Jones DR; Rudin CM; Solomon SB
    Radiology; 2017 Jan; 282(1):251-258. PubMed ID: 27440441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of colorectal resection combined with intraoperative radiofrequency ablation in treating colorectal cancer with liver metastasis and analysis of its prognosis.
    Fu T; He L; Liu F
    J BUON; 2020; 25(5):2171-2179. PubMed ID: 33277832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors.
    Liu L; Wang B; Zhang ZY; Wang S; Wu H; Wang H; Wu W; Yan K; Yang W
    Int J Hyperthermia; 2024; 41(1):2292950. PubMed ID: 38159558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis.
    Kim HS; Heo JS; Lee J; Lee JY; Lee MY; Lim SH; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim ST; Park JO; Lim HY; Choi YS; Kwon WI; Kim HC; Park YS
    BMC Cancer; 2016 Feb; 16():120. PubMed ID: 26887348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
    Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
    Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival.
    Serenari M; Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E
    Dig Surg; 2018; 35(4):303-310. PubMed ID: 29032374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method.
    Park J; Lee MW; Ahn SH; Han S; Min JH; Cha DI; Song KD; Kang TW; Rhim H
    Korean J Radiol; 2023 Aug; 24(8):761-771. PubMed ID: 37500577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
    Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
    Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
    Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
    Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
    Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.